Curtis Lockshin

Curtis A. Lockshin currently works at Ruth K.
Broad Biomedical Research Foundation, Inc., as Director from 2004 and Phio Pharmaceuticals Corp., as Independent Director from 2013.
Dr. Lockshin also formerly worked at Guardum Pharmaceuticals LLC, as President & Chief Executive Officer, SciVac Ltd., as Chief Executive Officer & Director from 2014 to 2016, SciVac Therapeutics, Inc., as Chief Executive Officer & Director from 2015 to 2016, Sumitomo Pharma America, Inc., as Director-Discovery Biology & Informatics from 1998 to 2002, clickNsettle.com, Inc., as Director from 2007 to 2008, Orthodontix, Inc., as Director in 2006, Getting Ready Corp., as Director from 2006 to 2008, BG Medicine, Inc., as Director-Discovery Biology from 2002 to 2003, Quikbyte Software, Inc., as Director from 2008 to 2009, Niagen Bioscience, Inc., as Independent Non-Executive Director from 2011 to 2014, Tiger X Medical, Inc., as Director, Winston Pharmaceuticals, Inc., as Director from 2008 to 2010, Sorrento Therapeutics, Inc., as Independent Director from 2008 to 2012, Xenetic Biosciences (UK) Ltd., as Vice President-Research & Operations from 2014 to 2017, OPKO Health, Inc., as Vice President-Research & Development Initiatives from 2011 to 2013, VBI Vaccines, Inc., as Chief Technical Officer in 2016, and Xenetic Biosciences, Inc., as Chief Scientific Officer from 2017 to 2024.
Dr. Lockshin received his undergraduate degree and doctorate degree from Massachusetts Institute of Technology.